Дата |
---|
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
18.04.2024 |
17.04.2024 |
16.04.2024 |
15.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
210.00
|
257.15
|
227.39
|
227.39
|
230.86
|
229.03
|
|
|
73 826 969.44
|
11 205.00
|
210.00
|
259.98
|
237.31
|
225.965
|
237.31
|
227.81
|
|
|
174 433 513.91
|
17 965.00
|
210.00
|
259.98
|
239.28
|
237.44
|
244.56
|
239.43
|
|
|
169 127 569.37
|
16 655.00
|
185.00
|
259.98
|
237.83
|
236.22
|
242.91
|
240.13
|
|
|
146 915 683.54
|
17 544.00
|
185.00
|
259.98
|
228.95
|
225.79
|
232.665
|
232.56
|
|
|
125 994 565.47
|
12 532.00
|
190.00
|
259.98
|
227.14
|
225.6468
|
230.34
|
226.78
|
|
|
92 949 406.81
|
11 052.00
|
185.00
|
259.98
|
228.02
|
223.49
|
233.72
|
227.55
|
|
|
162 577 096.26
|
15 898.00
|
190.00
|
231.00
|
234.40
|
229.85
|
234.40
|
230.09
|
|
|
115 256 419.69
|
12 237.00
|
190.00
|
259.98
|
235.92
|
231.395
|
235.92
|
232.34
|
|
|
78 216 398.99
|
10 842.00
|
195.00
|
259.98
|
244.32
|
234.17
|
244.41
|
235.93
|
|
|
109 553 147.39
|
12 872.00
|
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services.
Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Показать все Скрыть